Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous immunoglobulin for unexplained secondary recurrent miscarriage
2008-001589-94Phase 3Completed
- Sponsor
- Rigshospitalet
- Start
- May 2008
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in recurrent miscarriage (RPL) comparing Intravenous immunoglobulin with Placebo (2 arms). Started May 2008; status: completed.
02
Drugs
immune globulin
03
Conditions
recurrent miscarriage (RPL)
Beyond the preview
Go deeper on 2008-001589-94.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-001589-94.